Medicinal Plants | ~4 min read The market is splitting in two and pharma-grade botanical nutraceutical is one of them For years, the nutraceutical industry sourced botanical ingredients the same way the food industry sourced spices: in bulk, from commodity suppliers, with minimal documentation beyond a basic certificate of analysis. The primary selection criteria were price per kilogram and availability. For many products, this was adequate. A dried leaf blend destined for

BotaniX expertise | ~4 min read Dried plant material was the default, but that is changing. For most of the history of botanical ingredient supply, the standard format was simple: dried plant material, ground to a coarse or medium powder, shipped in bulk. Formulators received it, tested it, and worked with whatever particle size distribution the supplier delivered. The result was adequate for many applications, but it introduced variability at the formulation stage that man

Medicinal Plants | ~4 min read In and out products to enhance skin beauty and longevity The wall between cosmetics and nutrition is dissolving For decades, the skincare industry and the supplement industry operated as separate worlds. They served the same consumer, often with the same botanical species, but through entirely different supply chains, regulatory frameworks, and product development cultures. A cosmetics formulator sourcing Centella asiatica extract for a serum

The supply chain that nobody questioned For decades, the global botanical ingredients industry operated on a straightforward model: source raw plant material from tropical and subtropical regions where labour is inexpensive and biodiversity is abundant, process it through a chain of intermediaries, and deliver it to European manufacturers for formulation. The primary selection criteria were price and availability. The system worked well enough when nobody looked too closely a